Drug discovery targeting bromodomain-containing protein 4

Z Liu, P Wang, H Chen, EA Wold, B Tian… - Journal of medicinal …, 2017 - ACS Publications
BRD4, the most extensively studied member of the BET family, is an epigenetic regulator
that localizes to DNA via binding to acetylated histones and controls the expression of …

Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery

D Liang, Y Yu, Z Ma - European journal of medicinal chemistry, 2020 - Elsevier
As epigenetic readers of the histone code, BRD4 is the most extensively and thoroughly
studied member of BET family, which plays a critical role in many human diseases including …

Discovery of Benzo[cd]indol-2(1H)-ones and Pyrrolo[4,3,2-de]quinolin-2(1H)-ones as Bromodomain and Extra-Terminal Domain (BET) Inhibitors with Selectivity for …

F Jiang, Q Hu, Z Zhang, H Li, H Li… - Journal of medicinal …, 2019 - ACS Publications
The bromodomain and extra-terminal domain (BET) family of proteins are readers which
specifically recognize histone-acetylated lysine residues. Each BET bromodomain protein …

Discovery of 1H-Imidazo[4,5-b]pyridine Derivatives as Potent and Selective BET Inhibitors for the Management of Neuropathic Pain

X Chen, D Cao, C Liu, F Meng, Z Zhang… - Journal of medicinal …, 2023 - ACS Publications
Neuropathic pain (NP) is an intolerable pain syndrome that arises from continuous
inflammation and excitability after nerve injury. Only a few NP therapeutics are currently …

Recent advances in the applications of small molecules in the treatment of multiple myeloma

HN Abramson - International Journal of Molecular Sciences, 2023 - mdpi.com
Therapy for multiple myeloma (MM), a hematologic neoplasm of plasma cells, has
undergone remarkable changes over the past 25 years. Small molecules (molecular weight …

Epigenetic targets and their inhibitors in cancer therapy

L Zhao, YT Duan, P Lu, ZJ Zhang… - Current topics in …, 2018 - ingentaconnect.com
Epigenetics is defined as the stable and heritable alternations in gene expression without
changing the DNA nucleotide sequence. The initiation and progression of cancer result from …

Research progress in antineoplastic, antibacterial, and anti-inflammatory activities of seven-membered heterocyclic derivatives

B Li, C Chen, J Jia, L He - Current Medicinal Chemistry, 2022 - ingentaconnect.com
Seven-membered heterocyclic compounds are important drug scaffolds because of their
unique chemical structures. They widely exist in natural products and show a variety of …

Discovery of 2-((2-methylbenzyl) thio)-6-oxo-4-(3, 4, 5-trimethoxyphenyl)-1, 6-dihydropyrimidine-5-carbonitrile as a novel and effective bromodomain and extra …

X Chen, F Meng, J Zhang, Z Zhang, X Ye… - European Journal of …, 2022 - Elsevier
Sepsis has long been a major health problem worldwide. It threatens the lives of
hospitalized patients and has been one of the leading causes of death in hospitalized …

Future of personalized therapy targeting aberrant signaling pathways in multiple myeloma

F Anwer, KM Gee, A Iftikhar, M Baig, AD Russ… - … Myeloma and Leukemia, 2019 - Elsevier
Multiple myeloma (MM) is a genetically complex disease. Identification of mutations and
aberrant signaling pathways that contribute to the progression of MM and drug resistance …

Functional stratification of cancer drugs through integrated network similarity

S Unsal-Beyge, N Tuncbag - NPJ Systems Biology and Applications, 2022 - nature.com
Drugs not only perturb their immediate protein targets but also modulate multiple signaling
pathways. In this study, we explored networks modulated by several drugs across multiple …